REGENXBIO Inc.
RGNX
$9.66
$0.293.10%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -11.88% | -83.91% | 14.63% | 25.50% | 27.17% |
| Total Depreciation and Amortization | -3.00% | -2.96% | -3.70% | -4.59% | -6.46% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 70.20% | 70.02% | 31.93% | -8.95% | -17.61% |
| Change in Net Operating Assets | -380.62% | -120.38% | 112.90% | 714.33% | 1,259.92% |
| Cash from Operations | -180.67% | -178.17% | 28.40% | 43.32% | 54.02% |
| Capital Expenditure | -6.17% | 9.58% | 0.90% | -20.22% | 21.58% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 9,465.16% | -90.86% | -112.71% | -110.19% | -102.63% |
| Cash from Investing | 4,290.97% | -92.61% | -115.34% | -113.52% | -106.03% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 1,344.41% | 22.69% | -98.98% | -99.02% | -98.95% |
| Repurchase of Common Stock | -86.47% | -67.72% | 34.54% | 34.54% | 47.26% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -128.94% | 412.13% | 388.82% | 364.60% | 359.81% |
| Cash from Financing | -111.09% | 421.92% | 25.99% | 34.09% | 21.51% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -297.64% | -770.65% | -200.24% | -34.72% | 297.04% |